Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Gallic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 known ✓ | P27487 | 1/20 | 0.81 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.81 |
| ▸ | CA12 | O43570 | 4/20 | 0.81 |
| ▸ | CA1 | P00915 | 4/20 | 0.81 |
| ▸ | CA2 | P00918 | 4/20 | 0.81 |
| ▸ | CA7 | P43166 | 4/20 | 0.81 |
| ▸ | CA9 | Q16790 | 4/20 | 0.81 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.81 |
| ▸ | MAPT | P10636 | 3/20 | 0.81 |
| ▸ | LMNA | P02545 | 3/20 | 0.81 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.81 |
| ▸ | CA4 | P22748 | 3/20 | 0.81 |
| ▸ | CA6 | P23280 | 3/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.81 |
| ▸ | FUT7 | Q11130 | 2/20 | 0.81 |
| ▸ | CA3 | P07451 | 2/20 | 0.81 |
| ▸ | CA5A | P35218 | 2/20 | 0.81 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.81 |
| ▸ | TP53 | P04637 | 1/20 | 0.81 |
| ▸ | SELL | P14151 | 1/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gallic Acid SCHEMBL29249935 | 0.98 | KDM4E (0.77) | KDM4ECA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL30375631 | 0.90 | CA12 (1.00) | KDM4ECA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL15012 | 0.90 | CA12 (1.00) | KDM4ECA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL4918056 | 0.90 | CA12 (1.00) | KDM4ECA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL8088102 | 0.90 | CA12 (1.00) | KDM4ECA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL29484566 | 0.90 | CA12 (1.00) | KDM4ECA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL678990 | 0.90 | CA12 (1.00) | KDM4ECA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL1845406 | 0.90 | CA12 (1.00) | KDM4ECA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL1738964 | 0.87 | CA12 (0.94) | KDM4ECA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL1334688 | 0.87 | CA12 (0.94) | KDM4ECA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118026247-A | Method for preparing gallium oxide from gallium-containing solution | 中国科学院过程工程研究所 | 2024-05-14 | — | — | CN | disclosed |
| CN-108602054-A | High charge density metal phosphate molecular sieve | 环球油品公司 | 2018-09-28 | — | — | CN | disclosed |
| CN-108602053-A | High Charge Density Metal Phosphate Molecular Sieves | 环球油品公司 | 2018-09-28 | — | — | CN | disclosed |
| CN-108602053-A | High Charge Density Metal Phosphate Molecular Sieves | 环球油品公司 | 2018-09-28 | — | — | CN | disclosed |
| CN-106525938-A | A composite material modified electrode used for gallic acid concentration determination and applications thereof | 浙江大学 | 2017-03-22 | — | — | CN | disclosed |
| EP-1805191-B1 | Phosphorylated polyphenols as colour-stable agents | AJINOMOTO OMNICHEM S A (BE) | 2011-12-14 | — | — | EP | disclosed |
| US-20080076833-A1 | Phosphorylated Polyphenols as Colour-Stable Agents | AJINOMOTO OMNICHEM S.A. (BE) | 2008-03-27 | — | — | US | disclosed |
| EP-1805191-A1 | PHOSPHORYLATED POLYPHENOLS AS COLOUR-STABLE AGENTS | Ajinomoto Omnichem S.A. (BE) | 2007-07-11 | — | — | EP | disclosed |
| WO-2006029483-A1 | PHOSPHORYLATED POLYPHENOLS AS COLOUR-STABLE AGENTS | AJINOMOTO OMNICHEM S.A. (BE) | 2006-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080076833-A1 | Phosphorylated Polyphenols as Colour-Stable Agents | PPP4C, PTMS, CHAMP1 | DPP4 1183/4885KDM4E 605/4885CA12 4560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.